Global Encephalopathy Therapeutics Report 2016 - Pipeline Review of 12 Companies & Drug Profile Activity - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Encephalopathy - Pipeline Review, H1 2016" report to their offering.

This report provides comprehensive information on the therapeutic development for Encephalopathy, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Encephalopathy) and special features on late-stage and discontinued projects.

The report enhances decision-making capabilities and helps to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Key Topics Covered:

  1. Introduction
  2. Encephalopathy Overview
  3. Therapeutics Development
  4. Pipeline Products for Encephalopathy - Overview
  5. Pipeline Products for Encephalopathy - Comparative Analysis
  6. Encephalopathy - Therapeutics under Development by Companies
  7. Encephalopathy - Therapeutics under Investigation by Universities/Institutes
  8. Encephalopathy Products Glance
  9. Late Stage Products
  10. Clinical Stage Products
  11. Early Stage Products
  12. Encephalopathy - Products under Development by Companies
  13. Encephalopathy - Products under Investigation by Universities/Institutes
  14. Encephalopathy - Companies Involved in Therapeutics Development
  • Amarantus Bioscience Holdings, Inc.
  • Celgene Corporation
  • Chiesi Farmaceutici SpA
  • Fera Pharmaceuticals, LLC
  • GW Pharmaceuticals Plc
  • JS Genetics Inc.
  • KannaLife Sciences, Inc.
  • ProThera Biologics, LLC.
  • SciFluor Life Sciences, LLC
  • Turing Pharmaceuticals AG
  • Versantis
  • Zambon Company S.p.A.

For more information visit http://www.researchandmarkets.com/research/bphkcr/encephalopathy

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Central Nervous System Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Central Nervous System Drugs